PHASE-II EVALUATION OF RECOMBINANT GAMMA-INTERFERON IN PATIENTS WITH ADVANCED PANCREATIC-CARCINOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY

被引：0
|
作者：
VONHOFF, DD
FLEMING, TR
MACDONALD, JS
GOODMAN, PJ
VANDAMME, J
BROWN, TD
OROURKE, T
FEUN, LG
KEPPEN, MD
机构：
[1] UNIV TEXAS,HLTH SCI CTR,SAN ANTONIO,TX 78284
[2] UNIV KENTUCKY,MED CTR,LEXINGTON,KY 40506
[3] SW ONCOL GRP,CTR STAT,SEATTLE,WA
[4] BROOKE ARMY MED CTR,FT SAM HOUSTON,TX 78234
[5] UNIV MIAMI,SCH MED,MIAMI,FL 33152
[6] UNIV ARKANSAS MED SCI HOSP,LITTLE ROCK,AR 72205
来源：
JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS | 1990年 / 9卷 / 06期
关键词：
GAMMA-INTERFERON; PANCREATIC CANCER;
D O I：
暂无
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Thirty evaluable patients with advanced carcinoma of the pancreas received treatment with either daily x 5 bolus or continuous infusion x 5 days recombinant-gamma-interferon. No responses were noted. Major toxicities included fever, hypotension, and flu-like symptoms. gamma-Interferon does not appear to be an active single agent for patients with advanced pancreatic cancer.
引用
下载
收藏
页码：584 / 587
页数：4
相关论文
共 50 条
  • [1] PHASE-II TRIAL OF RECOMBINANT-DNA GAMMA-INTERFERON IN ADVANCED COLORECTAL-CANCER - A SOUTHWEST ONCOLOGY GROUP-STUDY
    BROWN, TD
    GOODMAN, PJ
    FLEMING, T
    MACDONALD, JS
    OROURKE, T
    TAYLOR, SA
    NEEFE, JR
    GAYNOR, E
    JOURNAL OF IMMUNOTHERAPY, 1991, 10 (05): : 379 - 382
  • [2] PHASE-II EVALUATION OF MITOXANTRONE IN ADVANCED PANCREATIC-CARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    TAYLOR, SA
    FLEMING, T
    VONHOFF, DD
    MCCRACKEN, JD
    BUKOWSKI, RM
    TALLEY, RW
    NATALE, RB
    GUY, JT
    SAMLOWSKI, WE
    COSTANZI, JH
    INVESTIGATIONAL NEW DRUGS, 1990, 8 (01) : 77 - 80
  • [3] PHASE-II EVALUATION OF DIAZIQUONE IN PANCREATIC-CARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    TILCHEN, EJ
    FLEMING, T
    MILLS, G
    OISHI, N
    BONNETT, JD
    NATALE, RB
    HARKER, G
    COLTMAN, CA
    CANCER TREATMENT REPORTS, 1987, 71 (12): : 1309 - 1310
  • [4] PHASE-II STUDY OF CONTINUOUS INFUSION RECOMBINANT GAMMA-INTERFERON IN RENAL-CARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    KUEBLER, JP
    GOODMAN, PJ
    BROWN, TD
    CRAWFORD, ED
    REITZ, CL
    KNIGHT, WA
    KISH, JA
    INVESTIGATIONAL NEW DRUGS, 1990, 8 (03) : 307 - 309
  • [5] PHASE-II TRIAL OF MERBARONE IN PANCREATIC-CARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP-STUDY
    KRAUT, EH
    FLEMING, T
    MACDONALD, JS
    SPIRIDONIDIS, CH
    BRADOF, JE
    BAKER, LH
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (04): : 327 - 328
  • [6] PHASE-II TRIAL OF AMSACRINE IN PANCREATIC-CARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    INAMASU, M
    OISHI, N
    CHEN, T
    LEGHA, S
    MCCRACKEN, J
    BALCERZAK, S
    STEPHENS, R
    OBRYAN, R
    RIVKIN, SE
    COSTANZI, JJ
    NATALE, RB
    BAKER, LH
    COLTMAN, CA
    CANCER TREATMENT REPORTS, 1984, 68 (11): : 1411 - 1412
  • [7] PHASE-II STUDY OF RECOMBINANT GAMMA-INTERFERON IN PATIENTS WITH ADVANCED NONOSSEOUS SARCOMAS
    EDMONSON, JH
    LONG, HJ
    CREAGAN, ET
    FRYTAK, S
    SHERWIN, SA
    CHANG, MN
    CANCER TREATMENT REPORTS, 1987, 71 (02): : 211 - 213
  • [8] PHASE-II TRIAL OF BISANTRENE IN PATIENTS WITH ADVANCED SARCOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    COWAN, JD
    GEHAN, E
    RIVKIN, SE
    JONES, SE
    CANCER TREATMENT REPORTS, 1986, 70 (05): : 685 - 686
  • [9] PHASE-II STUDY OF DIAZIQUONE IN UNTREATED ADVANCED GASTRIC-CARCINOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    PUGH, RP
    FLEMING, T
    GUY, JT
    WEICK, JK
    WARD, JH
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (01): : 11 - 13
  • [10] PHASE-II STUDY OF PIBENZIMOL IN PANCREATIC-CANCER - A SOUTHWEST ONCOLOGY GROUP-STUDY
    KRAUT, EH
    FLEMING, T
    SEGAL, M
    NEIDHART, JA
    BEHRENS, BC
    MACDONALD, J
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (01) : 95 - 96
12345